Dr. Jill O’Donnell-Tormey of the Cancer Research Institute joined me today to discuss cancer immunotherapy

Heralded by Science magazine last year as "Breakthrough of the Year," a growing number of cancer patients are relying on their own immune systems for treatment.

The novel treatment, cancer immunotherapy, uses the body’s immune system to fight cancer. It’s become a rapidly growing option, particularly for patients who have exhausted conventional treatments like radiation and chemotherapy.

Last summer results of an ongoing study of two immunotherapies found that more than 50% of patients with advanced melanoma had an 80% reduction in the size of their tumors by their first assessment. More than 90% of all responding patients continued to respond after 13 months.

Listen to Dr. Jill below.  Listen and #Consider!

The Cancer Research Institute (CRI) is the world's only nonprofit organization dedicated exclusively to harnessing the immune system's power to conquer all cancers. This important work has led to a promising new class of cancer treatments called cancer immunotherapy. These treatments mobilize, strengthen, and sustain the immune system's natural ability to destroy cancer cells, wherever they are in the body. CRI was founded in 1953 by Helen Coley Nauts to continue the work begun by her father, Dr. William B. Coley, who pioneered non-surgical, immune-based treatments for cancer.

Learn more.